Anti-dumping, Intra-industry Trade, and Quality Reversals

We examine an export game where two (home and foreign) firms produce vertically differentiated products. The foreign firm is more R&D efficient and is based in a larger and richer market. The unique (risk-dominant) Nash equilibrium exhibits intra-industry trade, and the foreign producer manufactures a higher-quality product. When transport costs are low, unilateral dumping by the foreign firm arises; otherwise, reciprocal dumping occurs. For some parameters, a domestic antidumping policy leads to a quality reversal in the international market whereby the home firm becomes the quality leader. This policy is desirable for the implementing country, though world welfare decreases

Overview of current regional and local scale air quality modelling practices: Assessment and planning tools in the EU

AbstractThe 2008 European Air Quality Directive (AQD) (2008/50/EC) encourages the use of models in combination with monitoring in a range of applications. It also requires Member States to design appropriate air quality plans for zones where the air quality does not comply with the AQD limit values. In order to cope with these various elements, a wide range of different modeling methods have been developed and applied by EU Member States in the last decade to assess the effects of local and regional emission abatement policy options on air quality and human health. However, an overall review of the methodologies that are used in different countries to compile local and regional air quality plans has not been performed so far. Such a review has been the objective of the APPRAISAL EU FP7 project with the main goal to identify methodologies and their limitations and to propose possible key areas to be addressed by research and innovation on the basis of this review. To fulfill these objectives, a structured online database of methodologies has been developed in collaboration with experts involved in the design of air quality plans (AQP). The current work relies on the APPRAISAL database which currently totals 59 contributions from 13 Member States. In this paper we summarize the outcome of the APPRAISAL project with respect to the review of current Integrated Assessment Modeling practices

HELGA VI. Giant molecular cloud associations in M31

VizieR online Data Catalogue associated with article published in journal Astronomical Journal (AAS) with title 'The Herschel Exploitation of Local Galaxy Andromeda (HELGA). VI. The distribution and properties of molecular cloud associations in M31.' (bibcode: 2015ApJ...798...58K

The Effect of Better Information on Income Inequality

Information system, Income inequality, Risk sharing markets, D80, J24, J30,

Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics

Aims: To describe the baseline characteristics of participants in the Acetazolamide in Decompensated Heart Failure with Volume Overload (ADVOR) trial and compare these with other contemporary diuretic trials in acute heart failure (AHF). Methods and results: ADVOR recruited 519 patients with AHF, clinically evident volume overload, elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) and maintenance loop diuretic therapy prior to admission. All participants received standardized loop diuretics and were randomized towards once daily intravenous acetazolamide (500 mg) versus placebo, stratified according to study centre and left ventricular ejection fraction (LVEF) (≤40% vs. >40%). The primary endpoint was successful decongestion assessed by a dedicated score indicating no more than trace oedema and no other signs of congestion after three consecutive days of treatment without need for escalating treatment. Mean age was 78 years, 63% were men, mean LVEF was 43%, and median NT-proBNP 6173 pg/ml. The median clinical congestion score was 4 with an EuroQol-5 dimensions health utility index of 0.6. Patients with LVEF ≤40% were more often male, had more ischaemic heart disease, higher levels of NT-proBNP and less atrial fibrillation. Compared with diuretic trials in AHF, patients enrolled in ADVOR were considerably older with higher NT-proBNP levels, reflecting the real-world clinical situation. Conclusion: ADVOR is the largest randomized diuretic trial in AHF, investigating acetazolamide to improve decongestion on top of standardized loop diuretics. The elderly enrolled population with poor quality of life provides a good representation of the real-world AHF population. The pragmatic design will provide novel insights in the diuretic treatment of patients with AHF. © 2022 European Society of Cardiology